Enhanced Cytotoxicity to Cancer Cells by Codelivery and Controlled Release of Paclitaxel-loaded Sirolimus-conjugated Albumin Nanoparticles.

MLA

Behrouz, Hossein, et al. “Enhanced Cytotoxicity to Cancer Cells by Codelivery and Controlled Release of Paclitaxel-Loaded Sirolimus-Conjugated Albumin Nanoparticles.” Chemical Biology & Drug Design, vol. 88, no. 2, Aug. 2016, pp. 230–40. EBSCOhost, https://doi.org/10.1111/cbdd.12750.

APA

Behrouz, H., Esfandyari-Manesh, M., Khoeeniha, M. K., Amini, M., Shiri Varnamkhasti, B., Atyabi, F., & Dinarvand, R. (2016). Enhanced Cytotoxicity to Cancer Cells by Codelivery and Controlled Release of Paclitaxel-loaded Sirolimus-conjugated Albumin Nanoparticles. Chemical Biology & Drug Design, 88(2), 230–240. https://doi.org/10.1111/cbdd.12750

Chicago

Behrouz, Hossein, Mehdi Esfandyari-Manesh, Mohammad Kazem Khoeeniha, Mohsen Amini, Behrang Shiri Varnamkhasti, Fatemeh Atyabi, and Rassoul Dinarvand. 2016. “Enhanced Cytotoxicity to Cancer Cells by Codelivery and Controlled Release of Paclitaxel-Loaded Sirolimus-Conjugated Albumin Nanoparticles.” Chemical Biology & Drug Design 88 (2): 230–40. doi:10.1111/cbdd.12750.